2-(aminomethyl)phenol
- Generic Name
- 2-(aminomethyl)phenol
- Drug Type
- Small Molecule
- Chemical Formula
- C7H9NO
- CAS Number
- 932-30-9
- Unique Ingredient Identifier
- 696R5N4NRM
- Background
2-(aminomethyl)phenol is under investigation in clinical trial NCT03556319 (2-HOBA: Multiple Dosing Study in Older Adults).
2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis
- First Posted Date
- 2022-03-10
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT05274243
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
Phase 2
Recruiting
- Conditions
- Familial Hypercholesterolemia
- Interventions
- Other: Placebo
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 72
- Registration Number
- NCT04941599
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 95
- Registration Number
- NCT04433091
- Locations
- 🇺🇸
Vanderbilt University Medical, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath